Precigen Newsroom

Precigen Reports Q3 2024 Financial Results

TipRanksNov 23 11:52

Precigen (NASDAQ:PGEN Shareholders Incur Further Losses as Stock Declines 13% This Week, Taking Five-year Losses to 86%

Yahoo FinanceNov 20 23:01

Stifel Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 15 21:35 · Ratings

Precigen Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow JonesNov 15 20:52 · Ratings

Precigen Analyst Ratings

BenzingaNov 15 20:41 · Ratings

H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 15 19:31 · Ratings

JMP Securities Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 15 13:32 · Ratings

Precigen's Strategic Advancements and FDA Alignment Bolster Buy Rating

TipRanksNov 15 13:25 · Ratings

Precigen | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:56 · Announcements

Precigen GAAP EPS of -$0.09 Misses by $0.01, Revenue of $0.95M Misses by $0.33M

Seeking AlphaNov 15 05:53

Precigen | 8-K: Precigen Reports Third Quarter 2024 Financial Results and Business Updates

SECNov 15 05:53

Express News | Precigen Reports Third Quarter 2024 Financial Results and Business Updates

BreakingsNov 15 05:30

Precigen 3Q Rev $953,000 >PGEN

Dow JonesNov 15 05:30

Precigen 3Q Loss $24M >PGEN

Dow JonesNov 15 05:30

Should You Hold Precigen (PGEN)?

Yahoo FinanceOct 18 20:15

Precigen Terminates License Agreement With Alaunos Therapeutics

WSJOct 11 06:31

Precigen Regains Full Control of Technology Post Agreement Termination

TipRanksOct 11 04:59

Express News | Precigen: Following Termination Co Has Regained All Rights Previously Licensed to Alaunos

BreakingsOct 11 04:36

Express News | Precigen: On Oct 4, a&R License Agreement Was Terminated

BreakingsOct 11 04:35

Express News | Alaunos Therapeutics : Co Provided Written Notice to Precigen to Terminate a&R License Agreement

BreakingsOct 10 20:32